MX351512B - Composición para el tratamiento de las verrugas. - Google Patents

Composición para el tratamiento de las verrugas.

Info

Publication number
MX351512B
MX351512B MX2014014278A MX2014014278A MX351512B MX 351512 B MX351512 B MX 351512B MX 2014014278 A MX2014014278 A MX 2014014278A MX 2014014278 A MX2014014278 A MX 2014014278A MX 351512 B MX351512 B MX 351512B
Authority
MX
Mexico
Prior art keywords
acid
warts
treatment
composition
pharmaceutical composition
Prior art date
Application number
MX2014014278A
Other languages
English (en)
Other versions
MX2014014278A (es
Inventor
Flemming Licht
Original Assignee
Abbex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbex Ab filed Critical Abbex Ab
Publication of MX2014014278A publication Critical patent/MX2014014278A/es
Publication of MX351512B publication Critical patent/MX351512B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica que comprende ácido fórmico y por lo menos un éster de alquilo de C1-C4 de ácido láctico, ácido málico, ácido tartárico, ácido cítrico, preferiblemente lactato de etilo, para el tratamiento tópico de las verrugas.
MX2014014278A 2012-05-28 2012-05-28 Composición para el tratamiento de las verrugas. MX351512B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2012/050566 WO2013180606A1 (en) 2012-05-28 2012-05-28 Composition for treatment of warts

Publications (2)

Publication Number Publication Date
MX2014014278A MX2014014278A (es) 2015-06-04
MX351512B true MX351512B (es) 2017-10-17

Family

ID=49673684

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014278A MX351512B (es) 2012-05-28 2012-05-28 Composición para el tratamiento de las verrugas.

Country Status (15)

Country Link
US (1) US10716857B2 (es)
JP (1) JP5934437B2 (es)
KR (1) KR101988693B1 (es)
CN (1) CN104363885A (es)
AU (1) AU2012381141B2 (es)
BR (1) BR112014029590A2 (es)
CA (1) CA2871990C (es)
EA (1) EA026621B1 (es)
HK (1) HK1206633A1 (es)
IL (1) IL235367B (es)
MX (1) MX351512B (es)
SG (1) SG11201407544XA (es)
UA (1) UA111785C2 (es)
WO (1) WO2013180606A1 (es)
ZA (1) ZA201409502B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3018687B1 (fr) * 2014-03-19 2017-04-14 Patrick Lepeytre " composition a base d'acides carboxyliques et son application pour le traitement des hyperkeratoses " -

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86107485A (zh) * 1986-10-29 1988-05-11 陈黄平 普通白酒勾兑成名酒香型酒技术
US5433950A (en) 1990-05-07 1995-07-18 Schering-Plough Healthcare Products, Inc. Flexible collodion compositions
US5476664A (en) 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
SE513436C2 (sv) * 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
KR20060104011A (ko) * 2005-03-29 2006-10-09 바이오이퀄 아게 사마귀 제거, 손발톱 질병의 치료 및 손발톱 관리에적용하기 위한 국소 제형
CN1939539A (zh) 2005-09-29 2007-04-04 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
US8691247B2 (en) * 2006-12-26 2014-04-08 Ad Lunam Labs Inc. Skin rejuvenation cream
EP2190425B1 (de) * 2007-04-20 2015-10-07 BioEqual AG Topisch anwendbare fungizide mittel zur nagelbehandlung
JP5248040B2 (ja) 2007-05-25 2013-07-31 リードケミカル株式会社 ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤
NL2003419C2 (en) * 2009-09-01 2011-03-02 Shieldmark Zacco Composition for tropical application, uses thereof, applicator device and kit of parts.
PT2460509T (pt) * 2010-12-06 2018-02-13 Abbex Ab Composição para tratamento de verrugas

Also Published As

Publication number Publication date
CA2871990A1 (en) 2013-12-05
JP2015517570A (ja) 2015-06-22
ZA201409502B (en) 2017-06-28
AU2012381141B2 (en) 2017-08-31
MX2014014278A (es) 2015-06-04
BR112014029590A2 (pt) 2017-06-27
CN104363885A (zh) 2015-02-18
WO2013180606A1 (en) 2013-12-05
EA026621B1 (ru) 2017-04-28
AU2012381141A1 (en) 2014-12-18
IL235367A0 (en) 2014-12-31
NZ702424A (en) 2017-02-24
SG11201407544XA (en) 2014-12-30
UA111785C2 (uk) 2016-06-10
IL235367B (en) 2019-05-30
CA2871990C (en) 2019-07-23
US10716857B2 (en) 2020-07-21
HK1206633A1 (en) 2016-01-15
EA201491927A1 (ru) 2015-05-29
KR101988693B1 (ko) 2019-06-12
US20150165031A1 (en) 2015-06-18
KR20150035533A (ko) 2015-04-06
JP5934437B2 (ja) 2016-06-15

Similar Documents

Publication Publication Date Title
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
MX337605B (es) Derivados de fumarato de acido graso y sus usos.
IN2014DN09434A (es)
IL231591A0 (en) Converted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
UA111542C2 (uk) Похідне складного ефіру 2-амінонікотинової кислоти та бактерицид, що містить зазначене похідне як активний інгредієнт
WO2012125544A3 (en) Necroptosis inhibitors and methods of use therefor
MX2021014242A (es) Uso de linagliptina en terapia antidiabetica cardio- y renoprotectora.
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
NZ720478A (en) Autotaxin inhibitor compounds
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
IN2014DN10670A (es)
NZ597510A (en) NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
EP2823819A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING OLEANOLIC ACID ACETATE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MEDIATED DISEASE BY TLR OR IL-6
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
EP3133073A3 (en) Inhibitors of iap
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
EP2818172A4 (en) TLR4 MEDIUM, TISSUE HOMEOSTAT, HEPATOCYTE GROWTH FACTOR INDUCTOR, TISSUE-DISAPPEARING AGENT, AND SIRTUINE INDUCTOR WITH HYALURONIC ACID FRAGMENTS AS ACTIVE AGENTS THEREOF
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
EP2709455A4 (en) PROCESSES FOR THE PREPARATION OF 5-AZASPIRO [2.4] HEPTANE-6-CARBOXYLIC ACID AND ITS DERIVATIVES
GB2515440A (en) Vesicular formulations
EP2692332A3 (en) Composition for the treatment of callus, corns, moles, telangiectasias, and psoriasis
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
WO2013033602A3 (en) Fatty acid amides, compositions and methods of use

Legal Events

Date Code Title Description
FG Grant or registration